Get started
Author

Giuseppe Della Pepa

Observed names: G Della Pepa, G. D. Pepa, G. Della Pepa, GIUSEPPE DELLA PEPA, Giuseppe Della Della Pepa
ORCID: 0000-0001-5862-3794
Observed ORCID: 0000-0001-5862-3794
OpenAlex ID: A5091084171
A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors
2021 · Anna Izzo, Elena Massimino, et al. · Nutrients · 447
PDF
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
2024 · Fabrizia Carli, Giuseppe Della Pepa, et al. · JHEP Reports · 182
A whole-grain cereal-based diet lowers postprandial plasma insulin and triglyceride levels in individuals with metabolic syndrome
2014 · R. Giacco, G. Costabile, et al. · Nutrition Metabolism and Cardiovascular Diseases · 133
Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity
2017 · M.‐R. Taskinen, S. Söderlund, et al. · Journal of Internal Medicine · 124
The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms
2021 · Elena Massimino, Anna Izzo, et al. · Cells · 117
PDF
Whole grain intake in relation to body weight: From epidemiological evidence to clinical trials
2011 · R. Giacco, G. Della Pepa, et al. · Nutrition Metabolism and Cardiovascular Diseases · 117
Polyphenol-rich diets improve glucose metabolism in people at high cardiometabolic risk: a controlled randomised intervention trial
2015 · Lutgarda Bozzetto, Giovanni Annuzzi, et al. · Diabetologia · 111
PDF
Dietary Fibre as a Unifying Remedy for the Whole Spectrum of Obesity-Associated Cardiovascular Risk
2018 · Lutgarda Bozzetto, Giuseppina Costabile, et al. · Nutrients · 98
Acute and chronic improvement in postprandial glucose metabolism by a diet resembling the traditional Mediterranean dietary pattern: Can SCFAs play a role?
2020 · Marilena Vitale, Rosalba Giacco, et al. · Clinical Nutrition · 96
Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial
2021 · Giuseppe Della Pepa, Marco Russo, et al. · Diabetes Research and Clinical Practice · 92
Wholegrain Intake and Risk of Type 2 Diabetes: Evidence from Epidemiological and Intervention Studies
2018 · Giuseppe Della Pepa, Claudia Vetrani, et al. · Nutrients · 92
PDF
Microelements for bone boost: the last but not the least
2016 · G Della Pepa · Clinical cases in mineral and bone metabolism · 75
PDF
Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals
2017 · Giuseppe Della Pepa, Claudia Vetrani, et al. · Nutrients · 71
Diets naturally rich in polyphenols and/or long-chain n-3 polyunsaturated fatty acids differently affect microbiota composition in high-cardiometabolic-risk individuals
2020 · Claudia Vetrani, Johanna Maukonen, et al. · Acta Diabetologica · 69
Plasma TMAO increase after healthy diets: results from 2 randomized controlled trials with dietary fish, polyphenols, and whole-grain cereals
2021 · Giuseppina Costabile, Claudia Vetrani, et al. · American Journal of Clinical Nutrition · 68
PDF
Association between different dietary polyphenol subclasses and the improvement in cardiometabolic risk factors: evidence from a randomized controlled clinical trial
2017 · Claudia Vetrani, Marilena Vitale, et al. · Acta Diabetologica · 59
Dietary Impact on Postprandial Lipemia
2020 · Lutgarda Bozzetto, Giuseppe Della Pepa, et al. · Frontiers in Endocrinology · 48
PDF
Effects of probiotic supplementation during pregnancy on metabolic outcomes: A systematic review and meta-analysis of randomized controlled trials
2020 · Maria Masulli, Ester Vitacolonna, et al. · Diabetes Research and Clinical Practice · 41
Effects of a diet naturally rich in polyphenols on lipid composition of postprandial lipoproteins in high cardiometabolic risk individuals: an ancillary analysis of a randomized controlled trial
2019 · Giuseppe Della Pepa, Claudia Vetrani, et al. · European Journal of Clinical Nutrition · 35
Evaluation of cardiovascular risk in adults with type 1 diabetes: poor concordance between the 2019 ESC risk classification and 10-year cardiovascular risk prediction according to the Steno Type 1 Risk Engine
2020 · Nicola Tecce, Maria Masulli, et al. · Cardiovascular Diabetology · 34
PDF
Natpara for the treatment of hypoparathyroidism
2016 · Gemma Marcucci, Giuseppe Della Pepa, et al. · Expert Opinion on Biological Therapy · 34
Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk
2016 · L. Bozzetto, G. Annuzzi, et al. · Nutrition Metabolism and Cardiovascular Diseases · 34
Reduction of De Novo Lipogenesis Mediates Beneficial Effects of Isoenergetic Diets on Fatty Liver: Mechanistic Insights from the MEDEA Randomized Clinical Trial
2022 · Giuseppina Costabile, Giuseppe Della Pepa, et al. · Nutrients · 28
PDF
Effects of a multifactorial ecosustainable isocaloric diet on liver fat in patients with type 2 diabetes: randomized clinical trial
2020 · Giuseppe Della Pepa, Claudia Vetrani, et al. · BMJ Open Diabetes Research & Care · 25
PDF
Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism
2017 · Gemma Marcucci, Giuseppe Della Pepa, et al. · Expert Opinion on Drug Safety · 24
Works count: 80
Citation count: 2,626
H-index: 24
I10-index: 45
Year
Topic
Type